Long-Term Safety and Efficacy of Stimulant Medications in Pediatric ADHD: Population-Based Cohort Study with Systematic Review
ADHD constitutes prevalent neurodevelopmental disorder affecting 5.29% children globally [1]. Core symptoms (hyperactivity, impulsivity, inattention) manifest across multiple settings causing significant cognitive, academic, behavioral impairment [9]. Untreated trajectory includes academic failure, social dysfunction, risk-taking behaviors [12]. Stimulantmedications modulate dopamine/norepinephrine neurotransmission representing first-line pharmacotherapy despite tachycardia, hypertension, psychosis concerns [3,4]. This systematic review synthesizes comprehensive long-term safety evidence […]

